On Dialogue: Disability Studies and Science & Technology Studies
By Laura Mauldin,
Somatosphere
| 05. 19. 2014
Untitled Document
I am grateful to Somatosphere for inviting to me to write a post for the blog. I was asked to write about the relationship between disability studies and science and technology studies (STS). So in this blog post, I want to explore some particular ways of thinking about this relationship.
I have been writing for some time now about the use of cochlear implants (CIs) in infants identified as deaf. I am currently finishing a book manuscript based on my dissertation research, which was a multi-sited ethnographic project in a CI clinic and other places encountered in the lives of families where a child received a CI. Throughout that project, I was interested in understanding and gathering stories about CIs in particular, but on a more general level I was trying to get at how a dual process – the increased medicalization of everyday life and the proliferation of new technologies — changes how we understand, act upon, cope with, and expect others to cope with human bodies. Part of what I want to do here is simply...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...